These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 850068)

  • 1. Hypogammaglobulinemia in experimental myeloma: the role of suppressor factors from mononuclear phagocytes.
    Krakauer RS; Strober W; Waldmann TA
    J Immunol; 1977 Apr; 118(4):1385-90. PubMed ID: 850068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
    Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
    Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Berney S; Goodis A; Schiffman G
    Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression in plasmacytoma: induction of suppressor cells.
    Chen Y; Hwang LT; Heller P
    Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of splenic suppressor cells in murine plasmacytoma.
    Chen Y; Heller P
    Clin Exp Immunol; 1981 Sep; 45(3):514-22. PubMed ID: 6461449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
    Joshua DE; Humphrey JH; Grennan D; Brown G
    Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased T gamma and T mu cells in BALB/c mice with IgG and IgM plasmacytomas and hybridomas.
    Mathur A; Lynch RG
    J Immunol; 1986 Jan; 136(2):521-5. PubMed ID: 2934474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an IgM plasmacytoma (TEPC-183) on the primary immune response of BALB/c mice.
    Havas HF; Schiffman G
    Immunology; 1978 Jan; 34(1):1-8. PubMed ID: 23993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells.
    Müller S; Hoover RG
    J Immunol; 1985 Jan; 134(1):644-7. PubMed ID: 3871117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the pharmacologic manipulation of suppressor cells associated with impaired immunoglobulin production.
    Morito T; Bankhurst AD; Williams RC
    J Lab Clin Med; 1980 Aug; 96(2):232-7. PubMed ID: 6447179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
    Elson CO; James SP; Graeff AS; Berendson RA; Strober W
    Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of T- and B-cell interactions in adult patients with combined immunodeficiency.
    Morito T; Bankhurst AD; Williams RC
    J Clin Invest; 1980 Feb; 65(2):422-31. PubMed ID: 6444306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: an immunologic profile. Cytotoxic and suppressive effects of the EA rosette-forming cell.
    Paglieroni T; Mackenzie MR
    J Immunol; 1980 Jun; 124(6):2563-70. PubMed ID: 7373038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.